POSTHERPETIC NEURALGIA
Clinical trials for POSTHERPETIC NEURALGIA explained in plain language.
Never miss a new study
Get alerted when new POSTHERPETIC NEURALGIA trials appear
Sign up with your email to follow new studies for POSTHERPETIC NEURALGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shingles pain breakthrough? drug may stop nerve damage before it starts
Prevention Recruiting nowThis study tests whether the oral medication venlafaxine can prevent postherpetic neuralgia, a chronic pain condition that often follows shingles. Researchers will enroll 832 adults with active shingles and moderate to severe pain. The goal is to see if early treatment with venla…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Prevention
Last updated May 14, 2026 12:01 UTC
-
New hope for shingles pain sufferers: Needle-Free treatment under study
Symptom relief Recruiting nowThis study tests a non-invasive treatment called transcutaneous pulsed radiofrequency for chronic pain after shingles (postherpetic neuralgia). Researchers want to see if it can reduce pain better than current options. The trial will enroll 35 adults with this condition and measu…
Matched conditions: POSTHERPETIC NEURALGIA
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Shingles pain relief showdown: which treatment wins?
Symptom relief Recruiting nowThis study compares two treatments for long-lasting nerve pain after shingles (postherpetic neuralgia). Researchers will test an ultrasound-guided nerve block and a radiofrequency treatment to see which provides better pain relief. The study involves 50 adults aged 18 to 80 who s…
Matched conditions: POSTHERPETIC NEURALGIA
Sponsor: Diskapi Teaching and Research Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
New pill aims to ease lingering shingles pain
Symptom relief Recruiting nowThis study tests a new drug called Y-4 to see if it can reduce pain from postherpetic neuralgia, a nerve pain that lingers after shingles. About 160 adults in China will take either Y-4 or the standard drug pregabalin for 14 weeks. Researchers will compare pain scores to find out…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 04, 2026 16:29 UTC